ResMed
resmed.comTotal trials
104
Active
15
Phase 3
1
Total enrollment
36,542
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Obstructive Sleep Apnea30
- Obstructive Sleep Apnea (OSA)8
- Chronic Obstructive Pulmonary Disease6
- Neuromuscular Disease5
- Heart Failure5
- Central Sleep Apnea4
- Respiratory Insufficiency4
- Obesity Hypoventilation Syndrome4
Frequently asked questions about ResMed
- How many clinical trials does ResMed have on ClinicalTrials.gov?
- ResMed is listed as the lead sponsor on 104 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of ResMed's trials are in Phase 3?
- 1 of ResMed's trials are in Phase 3.
- What therapeutic areas does ResMed focus on?
- ResMed's most-studied conditions on ClinicalTrials.gov are Obstructive Sleep Apnea, Obstructive Sleep Apnea (OSA), Chronic Obstructive Pulmonary Disease, Neuromuscular Disease, Heart Failure.